Sage therapeutics inc.

Major-Pharmaceuticals

SAGE


215 First Street
Cambridge , MA 02142

Executive/
Director

Price

  • Last Close
  • $ 5.55
    $ -2.54 -31.4 %
    Dec 9, 2024
  • 52-Week High/Low
  • $26.95 - $7.47
  • YTD
  • -74.4%

  • Trading Volume
  • 31,018
  • Market Cap Full
  • $ 332.8M
  • Shares Outstanding
  • 60M
    Oct 31, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 37.2% -45% 39.2% -2.2% 66% -5% -13.5% -20.9% 10% -13.5%
Q2 45.3% -6% 12.1% 7.4% 14.2% 4% -24.1% -4% 12.1% -
Q3 -42% 52.8% -21.8% -10.4% -22.4% 8% -21.1% 21.2% -56.2% -
Q4 37.8% 10.9% 160.2% -31% -48.6% 42.9% -5.1% -2.6% 9.7% -
J F M A M J J A S O N D
2024 18.3% -16.2% -12.8% -4.5% - - - - - - - -
2023 16.3% -6.1% 0.8% 16.4% 1.3% -5% -26.2% -42.3% 2.9% -9% 4.5% 10.7%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%59%-12%223%-42%-25%20%-51%-10%-43%-74%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.66 0.97 1.52 1.68 3.37 -2.44 -1.64 -2.07 -2.46
Q2 0.90 1.08 1.88 0.36 3.28 -2.63 -1.83 -2.13 -2.68
Q3 0.84 1.15 1.97 2.63 3.48 -2.03 -2.21 -2.31 -3.37
Q4 0.99 1.50 1.75 3.38 - 18.53 -2.12 -2.47 -
A 3.4 4.7 7.1 -8.1 -13.4 11.4 -7.8 -9 -8.51

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 47.1 51.9 58.4 59.1 59.7
Jun 46.5 51.1 51.9 58.5 59.1 59.8
Sep 46.7 51.7 52 58.8 59.4 59.9
Dec 46.9 51.8 52 58.9 59.5 60

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.9 0.7 92.8 0.5 11.3
Total Asset Turnover - - 0.5 - 0.1
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 39.1 153.7 -59.6 25.3 19.7
Equity multiplier - - - - -